Strides Pharma Science Faces USFDA Scrutiny Following Bengaluru Inspection
Strides Pharma Science Ltd, a prominent Indian pharmaceutical manufacturer, has received five observations from the United States Food and Drug Administration (USFDA) following a routine inspection of its Bengaluru-based manufacturing facility. The inspection, which concluded recently, has prompted a minor market reaction, with the company’s shares closing 0.75% lower at ₹1,145.00 on the Bombay Stock…